Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure?

Immunotherapy. 2014;6(6):667-9. doi: 10.2217/imt.14.49.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Liver Failure, Acute / immunology*
  • Liver Failure, Acute / prevention & control
  • Molecular Targeted Therapy / methods
  • Risk Assessment
  • Risk Factors
  • Secretory Leukocyte Peptidase Inhibitor / immunology*
  • Sepsis / immunology*
  • Sepsis / prevention & control
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*

Substances

  • SLPI protein, human
  • Secretory Leukocyte Peptidase Inhibitor